United Health Products, Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
UEECStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
BALANCE SHEETS
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $65,249 | $168,883 |
| Prepaid and other current assets | 40,143 | 22,800 |
| Total current assets | 105,392 | 191,683 |
| Deferred offering costs | 169,582 | - |
| Operating lease right-of-use asset | 14,574 | 47,096 |
| Security deposit | 2,850 | 2,850 |
| Patents, net | 24,300 | 28,350 |
| TOTAL ASSETS | $316,698 | $269,979 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | $1,052,255 | $830,672 |
| Accrued liabilities - related parties | 255,573 | 168,649 |
| Accrued compensation | 699,767 | 608,500 |
| Operating lease liability - current | 15,157 | 33,331 |
| Convertible notes payable – related party, net of debt discount | 500,000 | - |
| Convertible notes payable, net of debt discount | 1,279,149 | - |
| Derivative liabilities | 141,248 | - |
| Total current liabilities | 3,943,149 | 1,641,152 |
| Convertible notes payable, net of debt discount | - | 557,500 |
| Notes payable – related party | 250,000 | - |
| Convertible notes payable – related party, net of debt discount | - | 500,000 |
| Operating lease liability – long-term | - | 15,158 |
| TOTAL LIABILITIES | 4,193,149 | 2,713,810 |
| Commitments and Contingencies | - | - |
| Stockholders’ Deficit | ||
| Series A Convertible Preferred Stock - $0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding | - | - |
| Common Stock - $0.001 par value, 300,000,000 shares Authorized, 258,690,253 and 252,408,222 shares issued and outstanding at December 31, 2025 and December 31, 2024 | 258,690 | 252,408 |
| Additional Paid-In Capital | 77,235,150 | 76,004,704 |
| Accumulated Deficit | (81,370,291) | (78,700,943) |
| Total Stockholders’ Deficit | (3,876,451) | (2,443,831) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $316,698 | $269,979 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.